These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5946035)

  • 1. The distribution and excretion of tritiated substances in experimental animals following the administration of digoxin-3H.
    Harrison CE; Brandenburg RO; Ongley PA; Orvis AL; Owen CA
    J Lab Clin Med; 1966 May; 67(5):764-77. PubMed ID: 5946035
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolism of tritiated digoxin in renal insufficiency in dogs and man.
    Marcus FI; Peterson A; Salel A; Scully J; Kapadia GG
    J Pharmacol Exp Ther; 1966 Jun; 152(3):372-82. PubMed ID: 5922308
    [No Abstract]   [Full Text] [Related]  

  • 3. Alteration of the body distribution of tritiated digoxin by acute hyperkalemia in the dog.
    Marcus FI; Kapadia GG; Goldsmith C
    J Pharmacol Exp Ther; 1969 Jan; 165(1):136-48. PubMed ID: 5782830
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood and tissue levels and renal excretion of alpha-acetyldigoxin following intravenous administration in dogs].
    Kraupp O; Raberger G; Grossmann W
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(4):330-41. PubMed ID: 4234604
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasma levels and tissue distribution of 3H-digoxin.
    Binnion PF; Morgan LM
    Br Heart J; 1968 Nov; 30(6):871. PubMed ID: 5718999
    [No Abstract]   [Full Text] [Related]  

  • 6. Tissue concentration and turnover of tritiated digoxin in dogs.
    Doherty JE; Perkins WH
    Am J Cardiol; 1966 Jan; 17(1):47-52. PubMed ID: 5900337
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of acute hypokalemia on the myocardial concentration and body distribution of tritiated digoxin in the dog.
    Marcus FI; Nimmo L; Kapadia GG; Goldsmith C
    J Pharmacol Exp Ther; 1971 Aug; 178(2):271-81. PubMed ID: 5570455
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of reserpine on the metabolism of tritiated digoxin in the dog and in man.
    Marcus FI; Pavlovich J; Lullin M; Kapadia G
    J Pharmacol Exp Ther; 1968 Feb; 159(2):314-23. PubMed ID: 5638653
    [No Abstract]   [Full Text] [Related]  

  • 9. Biliary excretion of cardiac glycosides.
    Russell JQ; Klaassen CD
    J Pharmacol Exp Ther; 1973 Sep; 186(3):455-62. PubMed ID: 4728329
    [No Abstract]   [Full Text] [Related]  

  • 10. Species difference in duration of action of cardiac glycosides.
    Okita GT
    Fed Proc; 1967; 26(4):1125-30. PubMed ID: 6028775
    [No Abstract]   [Full Text] [Related]  

  • 11. H3-digoxin metabolism by adult male rat tissues in vitro.
    Lage GL; Spratt JL
    J Pharmacol Exp Ther; 1965 Aug; 149(2):248-56. PubMed ID: 5831045
    [No Abstract]   [Full Text] [Related]  

  • 12. Proceedings: The influence of spironolactone on the excretion and metabolism of 3H-digoxin in the rat.
    Wirth KE; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R107. PubMed ID: 4276675
    [No Abstract]   [Full Text] [Related]  

  • 13. An altered distribution and elimination of digoxin in anemic patients and experimentally induced anemic rats.
    Hamamoto H; Kitamura K; Takeda H; Bamba M; Takanashi T; Takino T
    Jpn Circ J; 1984 Nov; 48(11):1197-202. PubMed ID: 6502915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resorption, degradation and excretion of acetyldigoxin in animal experiments].
    Buchtela K; Drexler K; Hackl H; Königstein M; Schläger J
    Arzneimittelforschung; 1968 Mar; 18(3):295-303. PubMed ID: 5696004
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of binding of tritiated digoxin to myocardium by sodium depletion in dogs.
    Harrison CE; Wakim KG
    Circ Res; 1969 Feb; 24(2):263-8. PubMed ID: 5764586
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolism of digoxin: role of the liver in tritiated digoxin degradation.
    Abel RM LUCHI RJ; Peskin GW; Conn HL; Miller LD
    J Pharmacol Exp Ther; 1965 Dec; 150(3):463-8. PubMed ID: 5852880
    [No Abstract]   [Full Text] [Related]  

  • 17. Proceedings: Digoxin-concentrations in ischemic heart lesions in dogs.
    Kuhlmann J; Kötter V; von Leitner E
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R52. PubMed ID: 4276592
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship of the excretion of tritiated digoxin to renal function.
    Bloom PM; Nelp WB; Tuell SH
    Am J Med Sci; 1966 Feb; 251(2):133-44. PubMed ID: 5904731
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of 3H-digoxin in normal and acutely hyperkalaemic dogs.
    Morgan LM; Binnion PF
    Cardiovasc Res; 1970 Apr; 4(2):235-41. PubMed ID: 5419812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.